Research directory

Clinical trials

Search clinical trial records by company, ticker, trial title or NCT ID. Open a trial to compare changes to its completion date, participant count and main study measures.

Reset
1,647 trials match your filters. Primary completion is the end of data collection for the main study measures, not a results publication date.
TrialSponsorPhaseStatusPrimary completion
Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second RelapseNCT01068782ExelixisPhase 2Terminated2011-05Actual
Efficacy of To Be Marketed (TBM) Cholic Acid Capsules Used to Treat Children With Inborn Errors of Bile Acid SynthesisNCT01115582MIRMPhase 3Completed2010-08Actual
PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's DiseaseNCT01155362Celularity IncorporatedPhase 2Completed2012-02Actual
VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIVNCT01158157Emergent BioSolutionsPhase 3Completed2012-02-14Actual
Evaluation of the Tympanostomy Tube Delivery SystemNCT01202578Integra LifeSciences CorporationPhase 2, Phase 3Completed2010-11Actual
Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light PerceptionNCT01218789Vanda PharmaceuticalsPhase 3Unknown2024-12-05Estimated
Study on the Anti-tumor Activity, Safety and Pharmacology of IPH2101 in Patients With Smoldering Multiple MyelomaNCT01222286Innate PharmaPhase 2Completed2012-07Actual
Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's DiseaseNCT01233960Mesoblast, Inc.Phase 3Completed2014-09-15Actual
Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple MyelomaNCT01242930Geron CorporationPhase 2Completed2014-11Actual
Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)NCT01247207PTC TherapeuticsPhase 3Completed2026-02-10Actual
Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality TherapyNCT01265433Sellas Life Sciences GroupPhase 2Completed2016-11-30Actual
WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)NCT01266083Sellas Life Sciences GroupPhase 2Completed2016-09-30Actual
Relapse Prevention Study in Patients With SchizophreniaNCT01291511Vanda PharmaceuticalsPhase 3Completed2014-03Actual
Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)NCT01311674Emergent BioSolutionsPhase 3Terminated2011-03-11Actual
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate CancerNCT01436968CADLPhase 3Active not recruiting2024-08Actual
Open Label, Continuation Study of Cholic Acid in Subjects With Inborn Errors of Bile Acid SynthesisNCT01438411MIRMPhase 3Completed2016-07Actual
RP5063 in Subjects With Schizophrenia or Schizoaffective DisorderNCT01490086Reviva PharmaceuticalsPhase 2Completed2013-03Actual
Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy AdultsNCT01491607Emergent BioSolutionsPhase 3Completed2012-05Actual
Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue SarcomaNCT01514188IBRXPhase 2Completed2014-04-09Actual
Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic CancerNCT01580397IBRXPhase 2Completed2013-05-13Actual
Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental GlomerulosclerosisNCT01613118TVTXPhase 2Completed2016-06Actual
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung CancerNCT01630733Achieve Life SciencesPhase 3Completed2016-11-17Actual
Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.NCT01703754Alaunos TherapeuticsPhase 2Terminated2014-08-07Actual
Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese ParticipantsNCT01749137RYTMPhase 2Completed2013-09-28Actual
Ciprofloxacin BioThrax Co-Administration StudyNCT01753115Emergent BioSolutionsPhase 2Completed2013-08Actual
A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose LevelsNCT01770743Emergent BioSolutionsPhase 2Completed2014-02Actual
Comparison of Processed Nerve Allograft and Collagen Nerve Cuffs for Peripheral Nerve RepairNCT01809002Axogen CorporationPhase 3Completed2021-08-30Actual
Phase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast CancerNCT01828021MacroGenicsPhase 2Completed2016-12-07Actual
Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML PatientsNCT01838395BLRXPhase 2Completed2016-03Actual
Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsNCT01953926PBYIPhase 2Terminated2023-01-02Actual